Pubblicazioni

Rucaparib. An emerging parp inhibitor for treatment of recurrent ovarian cancer

2018 - CANCER TREATMENT REVIEWS

Musella, Angela; Bardhi, Erlisa; Marchetti, Claudia; Vertechy, Laura; Santangelo, Giusi; Sassu, Carolina; Tomao, Federica; Rech, Francesco; D'Amelio, Renzo; Monti, Marco; Palaia, Innocenza; Muzii, Ludovico; Benedetti Panici, Pierluigi

Nuclear Î²-arrestin1 is a critical cofactor of hypoxia-inducible factor-1Î± signaling in endothelin-1-induced ovarian tumor progression

2016 - ONCOTARGET

Cianfrocca, Roberta; Tocci, Piera; RosanÃ², Laura; Caprara, Valentina; Sestito, Rosanna; Di Castro, Valeriana; Bagnato, Anna

An overview of early investigational therapies for chemoresistant ovarian cancer

2015 - EXPERT OPINION ON INVESTIGATIONAL DRUGS

Marchetti, Claudia; Ledermann, Jonathan A.; BENEDETTI PANICI, Pierluigi

A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection

2015 - ANNALS OF SURGICAL ONCOLOGY

Angioli, Roberto; Capriglione, Stella; Aloisi, Alessia; Ricciardi, Roberto; Scaletta, Giuseppe; Lopez, Salvatore; Miranda, Andrea; Di Pinto, Anna; Terranova, Corrado; Plotti, Francesco